Anti-hyperlipidemic effect of methanol bark extract of Terminalia chebula in male albino Wistar rats

References

• Adeghate E, Ponery AS, Pallot DJ, Singh J. (2001). Distribution of vasoactive intestinal polypeptide, neuropeptide-Y and substance P and their effects on insulin secretion from the in vitro pancreas of normal and diabetic rats. Peptides 22:99–107
   PubMed Web of Science ®Google Scholar
• Babu R, Babu N, Chandra S, et al. (2012). Cardio tonic activity of aqueous extract of stem bark of Terminalia chebula on isolated frog’s heart. Int J Res Pharm Sci 3:24–8
   Google Scholar
• Bertolini S, Bon GB, Campbell LM, et al. (1997). Efficacy and safety of atorvastatin compared to pravastatin in patients with hypercholesterolemia. Atherosclerosis 130:191–7
   PubMed Web of Science ®Google Scholar
• Boden WE, Pearson TA. (2000). Raising low levels of high-density lipoprotein cholesterol is an important target of therapy. Am J Cardiol 85:645–50
   PubMed Web of Science ®Google Scholar
• Das C, Dsah S, Sahoo AC, et al. (2011). Antihyperlipidemic activity of Adenanthera pavonina Linn. ethanolic bark extract fractions. NPT 1:1–4
   Google Scholar
• Desu BSR, Saileela CH. (2013). Anti-hyperlipidemic activity of methanolic extract of Rhinacanthus nasutus. Int J Res Pharm Chem 3:708–11
   Google Scholar
• Dhulasavant V, Shinde S, Pawar M, Naikwade NS. (2011). Antihyperlipidemic activity of Cinnamomum tamala Nees. High cholesterol diet induced hyperlipidemia. Int J Pharm Life Sci 2:506–10
   Google Scholar
• Diaz MN, Balz Frel, Vita JA, Keaney JF. (1997). Antioxidants and atherosclerotic heart diseases. N Engl J Med 337:408–16
   PubMed Web of Science ®Google Scholar
• Elias J, Rajesh MG, Anish NP, et al. (2011). Terminalia chebula Retz. stem bark extract: A potent natural antioxidant. AJRC 4:445
   Google Scholar
• Fernandez ML, Webb D. (2008). The LDL to HDL cholesterol ratio as a valuable tool to evaluate coronary heart disease risk. J Am Coll Nutr 27:1–5
   PubMed Web of Science ®Google Scholar
• Ghosh R, Kadam PP, Kadam VJ. (2010). Antioxidant and hypolipidemic activity of Kumbhajatu in hypercholesterolemic rats. Int J Ayurveda Res 1:159–62
   PubMedGoogle Scholar
• Girija K, Lakshman K. (2011). Anti-hyperlipidemic activity of methanol extracts of three plants of Amaranthus in triton-WR 1339 induced hyperlipidemic rats. Asian Pac J Trop Biomed 1:S62–5
   Google Scholar
• Grundy SM. (2004). Obesity, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab 89:2595–600
   PubMed Web of Science ®Google Scholar
• Hassarajani S, Souza TD, Mengi SA, Chattopadhayay S. (2007). Efficacy study of the bioactive fraction (F-3) of Acorus calamus in hyperlipidemia. Indian J Pharmacol 39:196–200
   Google Scholar
• Indian Pharmacopoeia. (1985). Govt. of India, Ministry of Health of Family Welfare. New Delhi, India: The Controller of Publications
   Google Scholar
• Indulski JA, Lutz W. (1999). Ischaemic heart disease as an effect of obesity-related metabolic disturbances. Cent Eur J Public Health 7:122–9
   PubMedGoogle Scholar
• Israni DA, Patel KV, Gandhi TR. (2010). Antihyperlipidemic activity of aqueous extract of Terminalia chebula and Gaumutra in high cholesterol diet fed rats. Int J Pharm Sci 1:48–59
   Google Scholar
• Jebasingh D, Jackson DD, Venkataraman S, et al. (2014). The protective effects of Cyperus rotundus on behavior and cognitive function in a rat model of hypoxia injury. Pharm Biol 52:1558–69
   Google Scholar
• Kahn BB, Flier JS. (2000). Obesity and insulin resistance. J Clin Invest 106:473–81
   PubMed Web of Science ®Google Scholar
• Lee D, Boo K, Woo J, et al. (2011). Anti-bacterial and anti-viral activities of extracts from Terminalia chebula bark. J Korean Soc Appl Biol Chem 54:295–8
   Web of Science ®Google Scholar
• Lewington S, Whitlock G, Clarke R, et al. (2007). Blood cholesterol and vascular mortality by age, sex, and blood pressure: A meta-analysis of individual data from 61 prospective studies with 55 000 vascular deaths. Lancet 370:1829–39
   PubMed Web of Science ®Google Scholar
• Libby P. (1995). The molecular bases of acute coronary artery syndromes. Circulation 91:2844–50
   PubMed Web of Science ®Google Scholar
• Mahley RW, Bersot TP. (2006). Drug therapy for hypercholesterolemia and dyslipidemia. In: Brunton LL, ed. The Pharmacological Basis of Therapeutics. 11th ed. New York: McGraw Hill, 933–6
   Google Scholar
• Malloy MJ, Kane JP. (2007). Agents used in hyperlipidemia. In: Katzung BG, ed. Basic and Clinical Pharmacology. 10th ed. Boston: McGraw Hill, 560–72
   Google Scholar
• Marra F, Gastaldelli A, Svegliati Baroni G, et al. (2008). Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis. Trends Mol Med 14:72–81
   PubMed Web of Science ®Google Scholar
• Marzyieh Z, Rahimi AO, Mahdavi R, et al. (2007). Assessment of anti-hyperlipidemic effect of Citrullus colocynthis. Braz J Pharmacogn 17:492–6
   Google Scholar
• Mehta K, Balaraman R, Amin AH, et al. (2003). Effect of fruits of Moringa oleifera on the lipid profile of normal and hypercholesterolemic rabbits. J Ethnopharmacol 86:191–5
   PubMed Web of Science ®Google Scholar
• Misra A, Vikram NK. (2004). Insulin resistance syndrome (metabolic syndrome) and obesity in Asian Indians: Evidence and implications. Nutrition 20:482–91
   PubMed Web of Science ®Google Scholar
• Momiyama Y, Ohmori R, Fayad ZA, et al. (2012). The LDL-cholesterol to HDL-cholesterol ratio and the severity of coronary and aortic atherosclerosis. Atherosclerosis 222:577–80
   PubMedGoogle Scholar
• Moss JN, Dajani E. (1971). Antihyperlipidemic agents. In: Turner RA, Hebborn P, eds. Screening Methods in Toxicology. Vol. II. New York, London: Academic Press, 121–43
   Google Scholar
• Natarajan S, Glick H, Criqui M, et al. (2003). Cholesterol measures to identify and treat individuals at risk for coronary heart disease. Am J Prev Med 25:50–7
   PubMed Web of Science ®Google Scholar
• Pande VV, Dubey S. (2009). Antihyperlipidemic activity of Sphaeranthus indicus on atherogenic diet induced hyperlipidemia in rats. Int J Green Pharm 3:159–61
   Google Scholar
• Parekh S, Anania A. (2007). Abnormal lipid and glucose metabolism in obesity: Implications for nonalcoholic fatty liver disease. Gastroenterology 132:2191–2207
   PubMed Web of Science ®Google Scholar
• Parthasarathy S, Quinn MT, Schwenke DC, et al. (1989). Oxidative modification of beta very low density lipoprotein. Potential role of monocyte recruitment and foam cell formulation. Atherosclerosis 9:398–404
   Google Scholar
• Pedersen TR. (2001). Pro and con: Low density lipoprotein cholesterol lowering is and will be the key to the future of lipid management. Am J Cardiol 87:8B–12
   PubMedGoogle Scholar
• Punitha D, Thandavamoorthy A, Arumugasamy K, et al. (2012). Anti-hyperlipidemic effect of ethanolic leaf extract of Gmelina arborea in streptozotocin induced Wistar albino rats. Int J Life Sci Pharm Res 2:46–51
   Google Scholar
• Rang HP, Dale MM, Ritter JM, Flower PK. (2007). Pharmacology. 6th ed. London: Churchgill Livingstone
   Google Scholar
• Saravanan S, Srikumar R, Manikandan S, et al. (2007). Hypolipidemic effect of triphala in experimentally induced hypercholesteremic rats. Yakugaku Zasshi 27:385–8
   Google Scholar
• Scandinavian Simvastatin Survival Study Group. (1994). Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 344:1383–9
   PubMed Web of Science ®Google Scholar
• Sethupathy S, Elanchezhiyan C, Vasudevan K, Rajagopal G. (2002). Antiatherogenic effect of taurine in high fat diet fed rats. Indian J Exp Biol 40:1169–72
   PubMedGoogle Scholar
• Stauffer ME, Weisenfluh L, Morrison A. (2013). Association between triglycerides and cardiovascular events in primary populations: A meta-regression analysis and synthesis of evidence. Vasc Health Risk Manag 9:671–80
   PubMedGoogle Scholar
• Talbert RL. (2008). Hyperlipidemia. In: Dipiro TJ, Talbert RL, Yee GC, et al., eds. Pharmacotherapy: A Pathophysiological Approach, 7th ed. New York: McGraw Hill, 384–407
   Google Scholar
• Thompson GR. (1990). A Handbook of Hyperlipidemia. London, England: Current Science
   Google Scholar
• Visavadiya NP, Narasimhacharya AVRL. (2005). Hypolipidemic and antioxidant activities of Asparagus racemosus in hypercholesteremic rats. Indian J Pharmacol 37:376–80
   Google Scholar
• Wakil SJ, Abu-Elheiga LA. (2009). Fatty acid metabolism: Target for metabolic syndrome. J Lipid Res 50:S138–43
   PubMed Web of Science ®Google Scholar
• Walldius G, Jungner I. (2005). Rationale for using apolipoprotein B and apolipoprotein A-I as indicators of cardiac risk and as targets for lipid-lowering therapy. Eur Heart J 26:210–2
   PubMed Web of Science ®Google Scholar